- Docket No.
- 25-2236
- Appellate Court
- First Circuit
Goal
- Block enforcement of an agency action
- Declaration that agency action is unlawful
Issues
Case History
Litigation Content
Why this Matters:
The plaintiffs allege that a new 340B pilot rebate payment model violates the Administrative Procedure Act and imposes burdensome administrative and financial costs on participating hospitals. Instead of allowing hospitals to purchase a drug at a rebated price, the pilot model would require hospitals to pay drug manufacturers the full price of certain drugs up front and then seek a rebate once the drugs have been administered to eligible patients. The appeal challenges the lower court’s decision to preliminarily enjoin the model pilot program.
Potential Impact:
Hospitals argue that paying the full price of certain drugs up front will limit resources otherwise available for patient care and hamper hospitals’ ability to provide comprehensive care.
14 Major Filings
- MANDATE (Jan 20, 2026)
- JUDGMENT (Jan 20, 2026)
- DEFENDANTS' NOTICE OF VOLUNTARY DISMISSAL (Jan 16, 2026)
- PLAINTIFFS' RESPONSE TO MOTION TO INTERVENE (Jan 12, 2026)
- SCHEDULING ORDER (Jan 12, 2026)
- DEFENDANTS' NOTICE (Jan 12, 2026)
- ORDER ON MOTION FOR STAY PENDING APPEAL (Jan 7, 2026)
- AMICUS BRIEF [340B HEALTH ET AL.] (Jan 5, 2026)
- DEFENDANTS' RESPONSE RE: MOTION FOR STAY PENDING APPEAL (Dec 31, 2025)
- PLAINTIFFS' REPLY RE: MOTION FOR STAY PENDING APPEAL (Dec 31, 2025)
- SCHEDULING ORDER (Dec 31, 2025)
- MOTION TO INTERVENE ON APPEAL [PHARMACEUTICAL COMPANIES] (Dec 31, 2025)
- DEFENDANTS' MOTION FOR STAY PENDING APPEAL (Dec 30, 2025)
- DEFENDANTS' NOTICE OF APPEAL (Dec 29, 2025)